Exciting time to be doing research in GCA! Over half a dozen ongoing RCTs
Challenging to recruit enough patients given (1) competing trials (2) reticence to join a trial when tocilizumab (standard of care) is available
#ACR22 #Vasculitis22 @RheumNow
Challenging to recruit enough patients given (1) competing trials (2) reticence to join a trial when tocilizumab (standard of care) is available
#ACR22 #Vasculitis22 @RheumNow


